Clinical Trials Browser

Phase 2 × Brachytherapy × Sarcoma × Clear all

NCT01871766 2025-12-17

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

Phase 2 Active not recruiting

Rhabdomyosarcoma

NCT06023641 2025-08-19

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

Phase 2 Recruiting

Rhabdomyosarcoma

NCT06524778 2024-08-07

Single High-dose Brachytherapy for Giant Osteosarcoma Masses

Phase 2 Not yet recruiting

Osteosarcoma

NCT01552239 2018-10-16

PREMISS

Phase 2 Unknown

Sarcoma

NCT00002492 2016-12-15

Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma

Phase 2 Completed

Sarcoma

NCT00002804 2014-07-25

Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma

Phase 2 Completed

Sarcoma

NCT00002791 2014-01-24

Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma

Phase 2 Completed

Sarcoma

NCT00017160 2013-06-27

Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma

Phase 2 Withdrawn

Sarcoma

NCT00003574 2013-06-21

Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors

Phase 2 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma